Search for Clinical Trial Results

Sponsored By

Job Syndrome - 14 Studies Found

Status Study
Recruiting Study Name: Study of Clinical Features and Genetics of Hyperimmunoglobulin E Recurrent Infection
Condition: Job's Syndrome
Date: 2000-08-08
Recruiting Study Name: NFIL3-induced Pathological Enhancement of IgE Class Switch Recombination in Hyper-IgE Syndrome
Condition: Job Syndrome
Date: 2014-08-18
Recruiting Study Name: Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome
Condition: Autosomal-dominant Hyper-IgE Syndrome
Date: 2016-12-16
Interventions: Drug: NDV-3A A vaccine containing recombinant Candida albicans agglutinin-like sequence 3 (rAls3) protei
Completed Study Name: Omalizumab to Treat Hyper-IgE (Job's) Syndrome
Condition:
  • Hyper-IgE Syndrome
  • Job's Syndrome<
    Date: 2005-12-01
    Interventions: Drug: Omalizumab (Xolair)
Terminated Study Name: Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome
Condition:
  • JOB's Syndrome
  • Hyper-IgE Recurrent Infection Syndrome
  • Date: 2007-09-08
    Interventions:
    • Drug: Ranitidine Double blinde
Recruiting Study Name: Study of Mycobacterial Infections
Condition:
  • Atypical Mycobacterium Infections
  • Cystic Fibrosis
  • Date: 2001-06-28
Completed Study Name: Posaconazole to Treat Invasive Fungal Infections
Condition:
  • Granulomatous Disease, Chronic
  • Job's Syndrome
  • Healthy
  • Immunologic Deficiency Syndrome
  • Mycobacterium Infections, Atypical
  • Granulomatous Disease, Chronic
  • Chediak Higashi Syndrome
  • Chronic Granulomatous Disease
  • Date: 2000-07-04
Next >>>